Kmiec Eric B
Department of Biology, Delaware Biotechnology Institute, University of Delaware, Newark, Delaware 19716, USA.
J Clin Invest. 2003 Sep;112(5):632-6. doi: 10.1172/JCI19777.
The development of targeted gene repair is under way and, despite some setbacks, shows promise as an alternative form of gene therapy. This approach uses synthetic DNA molecules to activate and direct the cell's inherent DNA repair systems to correct inborn errors. The progress of this technique and its therapeutic potential are discussed in relation to the treatment of genetic diseases.
靶向基因修复技术正在发展,尽管遇到了一些挫折,但作为一种基因治疗的替代形式显示出了前景。这种方法使用合成DNA分子来激活并引导细胞固有的DNA修复系统,以纠正先天性错误。本文结合遗传病的治疗探讨了该技术的进展及其治疗潜力。